Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1990 Dec;137(6):1283–1291.

Myogenic regulatory protein (MyoD1) expression in childhood solid tumors: diagnostic utility in rhabdomyosarcoma.

P Dias 1, D M Parham 1, D N Shapiro 1, B L Webber 1, P J Houghton 1
PMCID: PMC1877713  PMID: 2260621

Abstract

Transcripts for the muscle regulatory gene MyoD1 are expressed during normal skeletal muscle myogenesis and in rhabdomyosarcomas but not in other tissues or in soft-tissue sarcomas. Here we report the distribution of MyoD1 protein, determined by reactivity with anti-MyoD1 polyclonal sera in normal tissues, rhabdomyosarcoma cell lines, and in a variety of pediatric solid tumors. The distribution of MyoD1 protein was highly restricted in normal tissues and was detected only in fetal skeletal muscle and more faintly in adult skeletal muscle. All six human rhabdomyosarcoma cell lines analyzed expressed MyoD1 mRNA transcripts as well as immunoreactive protein. The immunohistochemical expression of MyoD1 protein was then examined in 49 surgical specimens from a variety of pediatric solid tumors. Each of 16 rhabdomyosarcoma specimens was positive for MyoD1, including four that did not express the intermediate filament protein desmin. Two of five specimens originally designated sarcoma type indeterminate (STI) and two of three specimens originally designated extraosseous Ewing's sarcoma (EOE) were positive for MyoD1, suggesting commitment to myogenic differentiation. Three of eight Wilms' tumors, which also expressed desmin and had clearly evident myogenic elements, also were positive for MyoD1. Tumors that failed to express MyoD1 protein included neuroblastoma, primitive neuroectodermal tumor, non-Hodgkins lymphoma, embryonal sarcoma of the liver, malignant fibrous histiocytoma, malignant rhabdoid tumor, and Ewing's sarcoma of the bone. These results indicate that expression of MyoD1 protein is highly restricted in normal human tissues and that expression of this gene product in malignant tissue may be diagnostic for rhabdomyosarcoma. Furthermore MyoD1 staining may be a valuable adjunct in the classification of pediatric soft-tissue sarcomas.

Full text

PDF
1283

Images in this article

1284Figure 1
on p.1284
1288Figure 2
on p.1288

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altmannsberger M., Weber K., Droste R., Osborn M. Desmin is a specific marker for rhabdomyosarcomas of human and rat origin. Am J Pathol. 1985 Jan;118(1):85–95. [PMC free article] [PubMed] [Google Scholar]
  2. Beckwith J. B. Wilms' tumor and other renal tumors of childhood: a selective review from the National Wilms' Tumor Study Pathology Center. Hum Pathol. 1983 Jun;14(6):481–492. doi: 10.1016/s0046-8177(83)80003-3. [DOI] [PubMed] [Google Scholar]
  3. Davis R. L., Cheng P. F., Lassar A. B., Weintraub H. The MyoD DNA binding domain contains a recognition code for muscle-specific gene activation. Cell. 1990 Mar 9;60(5):733–746. doi: 10.1016/0092-8674(90)90088-v. [DOI] [PubMed] [Google Scholar]
  4. Davis R. L., Weintraub H., Lassar A. B. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell. 1987 Dec 24;51(6):987–1000. doi: 10.1016/0092-8674(87)90585-x. [DOI] [PubMed] [Google Scholar]
  5. Dias P., Kumar P., Marsden H. B., Morris-Jones P. H., Birch J., Swindell R., Kumar S. Evaluation of desmin as a diagnostic and prognostic marker of childhood rhabdomyosarcomas and embryonal sarcomas. Br J Cancer. 1987 Sep;56(3):361–365. doi: 10.1038/bjc.1987.203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Erlandson R. A. The ultrastructural distinction between rhabdomyosarcoma and other undifferentiated "sarcomas". Ultrastruct Pathol. 1987;11(2-3):83–101. doi: 10.3109/01913128709048318. [DOI] [PubMed] [Google Scholar]
  7. Feinberg A. P., Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 1983 Jul 1;132(1):6–13. doi: 10.1016/0003-2697(83)90418-9. [DOI] [PubMed] [Google Scholar]
  8. Garvin A. J., Drew S. W., Hintz D. S., Sens D. A. Tissue culture as a diagnostic technique for soft-tissue sarcoma of childhood. Arch Pathol Lab Med. 1984 Apr;108(4):308–310. [PubMed] [Google Scholar]
  9. Harms D., Schmidt D., Treuner J. Soft-tissue sarcomas in childhood. A study of 262 cases including 169 cases of rhabdomyosarcoma. Z Kinderchir. 1985 Jun;40(3):140–145. doi: 10.1055/s-2008-1059733. [DOI] [PubMed] [Google Scholar]
  10. Hirose T., Kudo E., Hasegawa T., Abe J., Hizawa K. Expression of intermediate filaments in malignant fibrous histiocytomas. Hum Pathol. 1989 Sep;20(9):871–877. doi: 10.1016/0046-8177(89)90099-3. [DOI] [PubMed] [Google Scholar]
  11. Houghton J. A., Houghton P. J. On the mechanism of cytotoxicity of fluorinated pyrimidines in four human colon adenocarcinoma xenografts maintained in immune-deprived mice. Cancer. 1980 Mar 15;45(5 Suppl):1159–1167. doi: 10.1002/1097-0142(19800315)45:5+<1159::aid-cncr2820451320>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  12. Hsu S. M., Raine L., Fanger H. A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am J Clin Pathol. 1981 May;75(5):734–738. doi: 10.1093/ajcp/75.5.734. [DOI] [PubMed] [Google Scholar]
  13. Johnson W., Jurand J., Hiramoto R. Immunohistologic studies of tumors containing myosin. Am J Pathol. 1965 Dec;47(6):1139–1155. [PMC free article] [PubMed] [Google Scholar]
  14. Kodet R. Rhabdomyosarcoma in childhood. An immunohistological analysis with myoglobin, desmin and vimentin. Pathol Res Pract. 1989 Aug;185(2):207–213. doi: 10.1016/S0344-0338(89)80253-5. [DOI] [PubMed] [Google Scholar]
  15. Lastarria D., Sachdev R. K., Babury R. A., Yu H. M., Nuovo G. J. Immunohistochemical analysis for desmin in normal and neoplastic ovarian stromal tissue. Arch Pathol Lab Med. 1990 May;114(5):502–505. [PubMed] [Google Scholar]
  16. MacDonald R. J., Swift G. H., Przybyla A. E., Chirgwin J. M. Isolation of RNA using guanidinium salts. Methods Enzymol. 1987;152:219–227. doi: 10.1016/0076-6879(87)52023-7. [DOI] [PubMed] [Google Scholar]
  17. Mukai M., Torikata C., Iri H., Mikata A., Hanaoka H., Kato K., Kageyama K. Histogenesis of alveolar soft part sarcoma. An immunohistochemical and biochemical study. Am J Surg Pathol. 1986 Mar;10(3):212–218. doi: 10.1097/00000478-198603000-00008. [DOI] [PubMed] [Google Scholar]
  18. Murre C., McCaw P. S., Vaessin H., Caudy M., Jan L. Y., Jan Y. N., Cabrera C. V., Buskin J. N., Hauschka S. D., Lassar A. B. Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell. 1989 Aug 11;58(3):537–544. doi: 10.1016/0092-8674(89)90434-0. [DOI] [PubMed] [Google Scholar]
  19. Newton W. A., Jr, Soule E. H., Hamoudi A. B., Reiman H. M., Shimada H., Beltangady M., Maurer H. Histopathology of childhood sarcomas, Intergroup Rhabdomyosarcoma Studies I and II: clinicopathologic correlation. J Clin Oncol. 1988 Jan;6(1):67–75. doi: 10.1200/JCO.1988.6.1.67. [DOI] [PubMed] [Google Scholar]
  20. Roholl P. J., De Jong A. S., Ramaekers F. C. Application of markers in the diagnosis of soft tissue tumours. Histopathology. 1985 Oct;9(10):1019–1035. doi: 10.1111/j.1365-2559.1985.tb02782.x. [DOI] [PubMed] [Google Scholar]
  21. Royds J. A., Variend S., Timperley W. R., Taylor C. B. An investigation of beta enolase as a histological marker of rhabdomyosarcoma. J Clin Pathol. 1984 Aug;37(8):905–910. doi: 10.1136/jcp.37.8.905. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Saku T., Tsuda N., Anami M., Okabe H. Smooth and skeletal muscle myosins in spindle cell tumors of soft tissue. An immunohistochemical study. Acta Pathol Jpn. 1985 Jan;35(1):125–136. doi: 10.1111/j.1440-1827.1985.tb02211.x. [DOI] [PubMed] [Google Scholar]
  23. Schmidt R. A., Cone R., Haas J. E., Gown A. M. Diagnosis of rhabdomyosarcomas with HHF35, a monoclonal antibody directed against muscle actins. Am J Pathol. 1988 Apr;131(1):19–28. [PMC free article] [PubMed] [Google Scholar]
  24. Schäfer B. W., Blakely B. T., Darlington G. J., Blau H. M. Effect of cell history on response to helix-loop-helix family of myogenic regulators. Nature. 1990 Mar 29;344(6265):454–458. doi: 10.1038/344454a0. [DOI] [PubMed] [Google Scholar]
  25. Scrable H., Witte D., Shimada H., Seemayer T., Sheng W. W., Soukup S., Koufos A., Houghton P., Lampkin B., Cavenee W. Molecular differential pathology of rhabdomyosarcoma. Genes Chromosomes Cancer. 1989 Sep;1(1):23–35. doi: 10.1002/gcc.2870010106. [DOI] [PubMed] [Google Scholar]
  26. Skalli O., Schürch W., Seemayer T., Lagacé R., Montandon D., Pittet B., Gabbiani G. Myofibroblasts from diverse pathologic settings are heterogeneous in their content of actin isoforms and intermediate filament proteins. Lab Invest. 1989 Feb;60(2):275–285. [PubMed] [Google Scholar]
  27. Tapscott S. J., Davis R. L., Thayer M. J., Cheng P. F., Weintraub H., Lassar A. B. MyoD1: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts. Science. 1988 Oct 21;242(4877):405–411. doi: 10.1126/science.3175662. [DOI] [PubMed] [Google Scholar]
  28. Truong L. D., Rangdaeng S., Cagle P., Ro J. Y., Hawkins H., Font R. L. The diagnostic utility of desmin. A study of 584 cases and review of the literature. Am J Clin Pathol. 1990 Mar;93(3):305–314. doi: 10.1093/ajcp/93.3.305. [DOI] [PubMed] [Google Scholar]
  29. Tsokos M., Kouraklis G., Chandra R. S., Bhagavan B. S., Triche T. J. Malignant rhabdoid tumor of the kidney and soft tissues. Evidence for a diverse morphological and immunocytochemical phenotype. Arch Pathol Lab Med. 1989 Feb;113(2):115–120. [PubMed] [Google Scholar]
  30. Tsokos M. The role of immunocytochemistry in the diagnosis of rhabdomyosarcoma. Arch Pathol Lab Med. 1986 Sep;110(9):776–778. [PubMed] [Google Scholar]
  31. Tsukada T., McNutt M. A., Ross R., Gown A. M. HHF35, a muscle actin-specific monoclonal antibody. II. Reactivity in normal, reactive, and neoplastic human tissues. Am J Pathol. 1987 May;127(2):389–402. [PMC free article] [PubMed] [Google Scholar]
  32. Weintraub H., Tapscott S. J., Davis R. L., Thayer M. J., Adam M. A., Lassar A. B., Miller A. D. Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. Proc Natl Acad Sci U S A. 1989 Jul;86(14):5434–5438. doi: 10.1073/pnas.86.14.5434. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES